Josephson M A, Spargo B, Hollandsworth D, Thistlethwaite J R
Department of Medicine, University of Chicago, Pritzker School of Medicine, IL.
Am J Kidney Dis. 1994 Nov;24(5):873-8. doi: 10.1016/s0272-6386(12)80685-8.
We describe the first reported case of a renal transplant patient who had two consecutive recurrences of membranous glomerulopathy in his allografts. Both recurrences were detected 1 year posttransplant. The first transplanted kidney was a none of six antigen match and his second was a four of six antigen match. The patient required a second kidney transplantation within 2 years of detection of the first recurrence. The second allograft has functioned adequately for nearly 4 years after diagnosis. The case and literature review illustrate that membranous glomerulopathy can recur in both poorly and well-matched allografts, that recurrence does not always occur faster in the better-matched kidneys, that cyclosporine does not prevent recurrent disease, and that the course of recurrent membranous glomerulopathy is unpredictable.
我们报告了首例肾移植患者同种异体移植肾连续两次发生膜性肾小球病复发的病例。两次复发均在移植后1年被检测到。首次移植的肾脏是6个抗原无匹配的,第二次是6个抗原4个匹配的。该患者在首次复发检测后的2年内需要进行第二次肾移植。第二次同种异体移植肾在诊断后已充分发挥功能近4年。该病例及文献综述表明,膜性肾小球病可在匹配不佳和匹配良好的同种异体移植肾中复发,复发并不总是在匹配更好的肾脏中更快发生,环孢素不能预防疾病复发,且复发性膜性肾小球病的病程不可预测。